HKTP: A Culturally Targeted Transplant Program

Sponsor
Northwestern University (Other)
Overall Status
Completed
CT.gov ID
NCT03276390
Collaborator
Mayo Clinic (Other), Baylor Health Care System (Other), University of Colorado, Denver (Other), The Methodist Hospital Research Institute (Other)
11,445
4
2
49.9
2861.3
57.3

Study Details

Study Description

Brief Summary

Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter patient and graft survival, and worse quality of life. Cultural beliefs and linguistic barriers contribute to the disparity in LDKTs. The objective of the proposed study is to implement and evaluate Northwestern Medicine's® Hispanic Kidney Transplant Program, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Hispanic Kidney Transplant Program (HKTP)
N/A

Detailed Description

The shortage of organs for kidney transplantation for patients with end-stage renal disease (ESRD) is magnified in Hispanics/Latin Americans. Hispanics have a disproportionately higher prevalence of ESRD, yet receive fewer kidney transplants compared to non-Hispanic whites. Living donor kidney transplant (LDKT) is the treatment of choice for ESRD as it confers better patient and graft survival, shorter waiting time, and better quality of life than deceased donor kidney transplantation. However, compared to their representation on the waiting list, fewer Hispanics received a LDKT than non-Hispanic whites in 2013: 4% versus 10%. Barriers to LDKT for Hispanics include: lack of knowledge, cultural concerns, and language barriers. The disparity will likely worsen without intervention as Hispanics are the largest and fastest growing minority group in the US.

Few available culturally competent interventions have led to increased LDKT rates. Interventions rarely address Hispanic cultural concerns, and there are no published models of transplant center-based only programs. The Chicago Northwestern Medicine's® Hispanic Kidney Transplant Program (HKTP), a culturally and linguistically competent program, has increased Hispanic LDKTs. The mean annual ratio of Hispanic to non-Hispanic white LDKTs grew from 0.20 in 2001-2006 to 0.34 in 2008-2013, a 70% increase (p<0.001).

The objective of this study is to implement and evaluate the HKTP, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations (Dallas, TX, and Los Angeles, CA), with Northwestern University serving as the Study Coordinating Center. The pre-post HKTP intervention study will evaluate the effect of the HKTP's key culturally sensitive components (outreach, communication, education) on

Hispanic LDKT rates, compared to matched controls. The specific aims are to:
  1. Implement the HKTP at two transplant centers by conducting a needs assessment of barriers and using a "learning collaborative" model to deliver HKTP protocols, scripts, and materials.

  2. Conduct a pre-post HKTP intervention evaluation with matched controls to assess if the HKTP is associated with an increase in: a) the ratio of Hispanic to non-Hispanic white LDKTs as a function of an absolute increase in Hispanic LDKTs, b) ESRD Hispanic patient additions to the waiting list, c) Hispanic potential donors per potential recipient, and

  1. Hispanic patients' satisfaction with care.
  1. Formatively evaluate the fidelity and innovative adaptations to HKTP's outreach, communication, and education at both study sites to identify effective components of the HTKP, using mixed methods.

As an exploratory aim, a budget impact analysis will be conducted to construct a business case for transplant centers and permit estimates of HKTP scalability. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally, improve health outcomes for Hispanics, and close the LDKT disparity gap.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
11445 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two group comparison (intervention vs. control) and pre-post comparison (within each site).Two group comparison (intervention vs. control) and pre-post comparison (within each site).
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Culturally Targeted Transplant Program to Increase Live Donation in Hispanics
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Feb 28, 2021
Actual Study Completion Date :
Feb 28, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention study site

Exposure to the intervention, which is the Northwestern Medicine (TM) Hispanic Kidney Transplant Program, a culturally targeted program for Hispanic potential recipients for transplant evaluation that is implemented into the 2 study sites. The intervention study site will provide the intervention to its Hispanic patients. The intervention study will will also provide the routine care (control arm) to all other patients. For the purposes of this study, Hispanic potential recipients recruited into the study will be exposed to this intervention. Non-Hispanic Whites recruited into the study will not be exposed to this intervention.

Behavioral: Hispanic Kidney Transplant Program (HKTP)
The HKTP entails culturally targeted education in Spanish about transplantation, outreach to dialysis patients by bicultural health care providers.

No Intervention: No intervention study site

Exposure to routine transplant evaluation at the two control sites.

Outcome Measures

Primary Outcome Measures

  1. Ratio of Hispanic to non-Hispanic white LDKTs [Post-intervention exposure up to 3.5 years]

    A center-level variable. This is a metric of disparity

Secondary Outcome Measures

  1. Number of Hispanic living kidney donors [Post-intervention exposure up to 3.5 years]

    A center-level variable. Exposure to the HKTP is expected to increase the number of Hispanic living kidney donors

  2. number of Hispanic ESRD patients added to the waiting list [Post-intervention exposure up to 3.5 years]

    A center-level variable.

  3. number of Hispanic potential donors per potential recipient [Post-intervention exposure up to 3.5 years]

    A center-level variable.

Other Outcome Measures

  1. satisfaction with culturally competent care [in year 1-2 and year 4.5]

    A center-level variable. The CAHPS survey questionnaire will be used. A mean level of satisfaction will be prospectively comparing routine care with culturally competent care.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hispanic or non-Hispanic white potential recipients initiating evaluation for a transplant

  • age 18 or older

  • The above potential recipients' potential donors initiating evaluation for living donation

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Arizon Phoenix Arizona United States 85054
2 University of Colorado Denver Denver Colorado United States 80045
3 Baylor University Medical Center Dallas Texas United States 75246
4 Houston Methodist Hospital Houston Texas United States 77030

Sponsors and Collaborators

  • Northwestern University
  • Mayo Clinic
  • Baylor Health Care System
  • University of Colorado, Denver
  • The Methodist Hospital Research Institute

Investigators

  • Principal Investigator: Elisa J Gordon, PhD, Northwestern University
  • Principal Investigator: Juan Carlos J Caicedo, MD, Northwestern University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Elisa Gordon, Professor, Northwestern University
ClinicalTrials.gov Identifier:
NCT03276390
Other Study ID Numbers:
  • 1R01DK104876-01
First Posted:
Sep 8, 2017
Last Update Posted:
Mar 18, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Elisa Gordon, Professor, Northwestern University

Study Results

No Results Posted as of Mar 18, 2021